Comparison 2. AB 103 versus placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Mortality within 30 days | 1 | 43 | Risk Ratio (M‐H, Random, 95% CI) | 0.34 [0.05, 2.16] |
2 Proportion of patients who experienced serious adverse events | 1 | 43 | Risk Ratio (M‐H, Random, 95% CI) | 1.49 [0.52, 4.27] |